At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia
In Brief
A clinical study evaluating Communication Bridge™ and Evidence-Based Impairment Focused for Primary Progressive Aphasia. Completed, enrolled 190 participants across 1 site.
Detailed Summary
This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech language therapy on communication abilities in individuals with PPA. Participants with a diagnosis of PPA and their actively-engaged care partners will be involved in the study for 12 months. Each participant will receive a laptop equipped with the necessary applications and features for the study. Participants will receive 5 evaluations and 15 speech therapy sessions with a licensed speech therapist, as well as access to Communication Bridge, a personalized web application to practice home exercises that reinforce treatment strategies. There are no costs to participate in this study.
Study Details
Timeline
Interventions
Evidence-based speech language therapy treatment will be compared and contrasted in the two arms of the study.
Evidence-based speech language therapy treatment will be compared and contrasted in the two arms of the study.